An isolated ulcer that heals in ten days does not pose a diagnostic problem. When outbreaks recur despite antiseptic mouthwashes and usual anesthetic gels, management must change approach. Recurrent aphthous stomatitis resistant to standard topicals indicates either an unidentified triggering factor or an underlying pathology that perpetuates the inflammatory cycle.
Biological assessment to prescribe for resistant recurrent ulcers
We recommend not to repeat the same local treatment after two or three closely spaced outbreaks without results. The priority is to request a targeted blood test.
Read also : The dangers of Budwig cream: what your health needs to know
The complete blood count remains the first examination. It detects anemia, neutropenia, or lymphopenia that alter the local immune response of the oral mucosa. A deficiency in iron, folates, vitamin B12, or zinc contributes to recurrent ulcers in a notable proportion of patients, and simply correcting the deficiency can sometimes suffice to space out the outbreaks.
When the baseline results return to normal, the question of recurrent ulcers despite treatment should lead to broader screening. Celiac serology (anti-transglutaminase antibodies), digestive inflammatory markers, and targeted autoimmune assessment deserve to be discussed with the treating physician or an internist.
See also : What budget to expect for a night of camping in France this year?
Medications responsible for oral aphthous ulcerations
An underestimated factor in everyday practice: some medications cause or worsen ulcers. Non-steroidal anti-inflammatory drugs, nicorandil, methotrexate, certain beta-blockers, and mTOR inhibitors are among the most frequently implicated molecules.
The difficulty lies in the delay of onset. Ulceration can occur several weeks after the introduction of treatment, which obscures the causal relationship. We regularly observe patients who multiply consultations for ulcers without their prescriptions being re-evaluated from this perspective.
The approach is simple: review the complete list of ongoing treatments, compare each molecule against pharmacovigilance databases, and propose a substitution when possible. Improvement within a few weeks confirms the attribution.
Systemic pathologies to consider when ulcers persist
Recurrent ulcers that do not respond to any local treatment should prompt the search for an underlying disease. Three diagnoses occur more frequently than others.
- Behçet’s disease: recurrent oral and genital ulcers, uveitis, skin involvement. Bipolar aphthosis (mouth and genital organs) is a strong warning signal, especially in a young adult from the Mediterranean basin or Asia.
- Celiac disease: recurrent ulcers may be the only extra-digestive manifestation for years before intestinal disorders become evident. The measurement of anti-transglutaminase antibodies and a duodenal biopsy confirm the diagnosis.
- Chronic inflammatory bowel diseases: Crohn’s disease and ulcerative colitis are accompanied by oral ulcerations that sometimes precede digestive symptoms. Abdominal pain, chronic diarrhea, or weight loss associated guide the assessment.
The PFAPA syndrome (periodic fever, aphthous stomatitis, pharyngitis, adenitis) mainly affects children. The outbreaks occur with almost calendar-like regularity, distinguishing it from classic recurrent aphthous stomatitis.
Treatments for recurrent aphthous stomatitis beyond topicals
When antiseptic mouthwashes and hyaluronic acid-based gels no longer control symptoms, several therapeutic options exist.
Potent topical corticosteroids
Strong class local corticosteroids (clobetasol propionate in magistral preparation, for example) applied directly to the lesion at the prodromal stage reduce the duration and pain of the outbreak. Application must begin at the pre-ulcerative burning stage to be fully effective. Too late an application, on an ulcer that has already been established for several days, offers limited benefit.
Sucralfate mouthwashes
Sucralfate, usually prescribed for gastroduodenal ulcers, forms a protective film on the damaged oral mucosa. Used as a mouthwash, it reduces pain and may accelerate healing. We willingly combine it with topical corticosteroids in severe forms.
Colchicine and systemic treatments
Low-dose colchicine represents the first-line foundational treatment for debilitating recurrent aphthous stomatitis. Its anti-inflammatory action on neutrophils reduces the frequency and intensity of outbreaks. Digestive tolerance remains the limiting factor.
For refractory forms, apremilast has been the subject of a French hospital clinical trial in recurrent oral aphthosis. This molecule, a phosphodiesterase 4 inhibitor, opens a perspective for patients failing previous lines of treatment.
Referral threshold: when to refer to a specialist
The treating physician or dentist manages the majority of recurrent aphthous stomatitis cases. Specialized advice (dermatologist, internist, stomatologist) becomes necessary in specific situations.
- Giant ulcers (diameter greater than one centimeter) that leave mucosal scars
- Overlapping outbreaks without a free interval for several months
- Ulcers associated with genital ulcerations, skin lesions, or ocular signs
- Documented failure of potent topical corticosteroids and colchicine
- Suspicion of systemic disease after an initial abnormal biological assessment
The giant form, known as Sutton’s disease, deserves special attention. Deep ulcerations heal over several weeks and can lead to scar bands that deform the oral mucosa, limiting nutrition.
An ulcer that does not heal after three weeks necessitates a biopsy to exclude squamous cell carcinoma, especially in a smoking patient or regular alcohol consumer. Any persistent single oral ulcer beyond three weeks requires specialized advice, regardless of the patient’s age.